2016
DOI: 10.1136/openhrt-2016-000448
|View full text |Cite
|
Sign up to set email alerts
|

Congenital heart disease and the cost of mortality

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 12 publications
0
5
0
Order By: Relevance
“…The cost implication is enormous and is shared by the family, hospital and the government. The cost of procuring medication and surgical treatment is usually more than anticipated (14)(15)(16). For most cases, surgical corrections is needed.…”
Section: Discussionmentioning
confidence: 99%
“…The cost implication is enormous and is shared by the family, hospital and the government. The cost of procuring medication and surgical treatment is usually more than anticipated (14)(15)(16). For most cases, surgical corrections is needed.…”
Section: Discussionmentioning
confidence: 99%
“…This has now created a new challenge, that of a growing adult population with CHD which exceeds the number of affected children born who require ongoing medical attention from repeated hospitalizations for surgical, catheter or non-surgical interventions [15]. Consequently, the morbidity and mortality-related economic burden placed on healthcare systems, as well, as patients and their families are astronomical [7,[16][17][18][19]. This economic burden underscores the urgency to identify the causes of CHD methodologies that could lead to strategies to prevent these defects in our children.…”
Section: Epidemiology Of Congenital Heart Diseasementioning
confidence: 99%
“…Congenital heart disease (CHD), which manifests as a morphologically defective heart, affects about 1% of newborn babies, and remains the primary cause of non-infectious children mortality in the developed world ( Gilboa et al, 2010 ; van der Linde et al, 2011 ). While CHD mortality rates have been dramatically reduced in recent years thanks to advances in surgical practice and interventional technologies ( Gilboa et al, 2010 ; Czosek and Anderson, 2016 ), CHD patients continue to be at an increased risk of developing heart failure at a much younger age than the general population ( Gilljam et al, 2019 ). Despite early indicators of success, heart failure continues to take the lives of young children with CHD: 10% to 25% of newborns with a critical heart defect do not survive the first year, and 44% do not survive to 18 years of age ( Oster et al, 2013 ; Stout et al, 2016 ).…”
Section: Introductionmentioning
confidence: 99%